Cargando…

Editorial: Pathogenic Advances and Therapeutic Perspectives for Eosinophilic Inflammation

Detalles Bibliográficos
Autores principales:	Roufosse, Florence E., Johansson, Mats W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127289/ https://www.ncbi.nlm.nih.gov/pubmed/30234117 http://dx.doi.org/10.3389/fmed.2018.00243

Ejemplares similares

Targeting the Interleukin-5 Pathway for Treatment of Eosinophilic Conditions Other than Asthma
por: Roufosse, Florence
Publicado: (2018)

Tissue Remodeling in Chronic Eosinophilic Esophageal Inflammation: Parallels in Asthma and Therapeutic Perspectives
por: Nhu, Quan M., et al.
Publicado: (2017)

Eosinophil Activation Status in Separate Compartments and Association with Asthma
por: Johansson, Mats W.
Publicado: (2017)

Eosinophils and eosinophilic immune dysfunction in health and disease
por: Jackson, David J., et al.
Publicado: (2022)

Cysteinyl Leukotrienes in Eosinophil Biology: Functional Roles and Therapeutic Perspectives in Eosinophilic Disorders
por: Thompson-Souza, Glaucia A., et al.
Publicado: (2017)

Platelet–Eosinophil Interactions As a Potential Therapeutic Target in Allergic Inflammation and Asthma
por: Shah, Sajeel A., et al.
Publicado: (2017)

Oral Corticosteroid Use for the Treatment of Chronic Eosinophilic Disease: A Patient’s and His Physician’s Experience
por: Silva, Mitchell, et al.
Publicado: (2019)

What does elevated TARC/CCL17 expression tell us about eosinophilic disorders?
por: Catherine, Julien, et al.
Publicado: (2021)

Editorial: Thrombotic Microangiopathies, Diagnostic and Therapeutic Advances
por: Maitta, Robert W., et al.
Publicado: (2021)

The Role of Eosinophils in Bullous Pemphigoid: A Developing Model of Eosinophil Pathogenicity in Mucocutaneous Disease
por: Amber, Kyle T., et al.
Publicado: (2018)

Editorial: Therapeutic Advancements in Psoriasis and Psoriatic Arthritis
por: Panda, Saumya
Publicado: (2022)

Prostaglandins and Their Receptors in Eosinophil Function and As Therapeutic Targets
por: Peinhaupt, Miriam, et al.
Publicado: (2017)

Transcription Factors in Eosinophil Development and As Therapeutic Targets
por: Fulkerson, Patricia C.
Publicado: (2017)

Eosinophils affect functions of in vitro-activated human CD3-CD4+ T cells
por: Harfi, Issam, et al.
Publicado: (2013)

Editorial: Advanced therapeutic delivery for the management of chronic respiratory diseases
por: Paudel, Keshav Raj, et al.
Publicado: (2022)

Eosinophilic granulomatosis with polyangiitis – Advances in pathogenesis, diagnosis, and treatment
por: Fijolek, Justyna, et al.
Publicado: (2023)

Pathogenic Effector Th2 Cells in Allergic Eosinophilic Inflammatory Disease
por: Mitson-Salazar, Alyssa, et al.
Publicado: (2017)

Editorial: Intestinal Inflammation
por: Pastorelli, Luca, et al.
Publicado: (2018)

Editorial: Sepsis and COVID-19: Cross-Talk in Signaling Pathways and in Therapeutic Perspectives
por: Salomão, Reinaldo, et al.
Publicado: (2022)

Editorial: Neurological Disorders and COVID-19: Interconnections, Molecular Links, and Therapeutic Perspectives
por: Khan, Suliman, et al.
Publicado: (2022)

Glycobiology of Eosinophilic Inflammation: Contributions of Siglecs, Glycans, and Other Glycan-Binding Proteins
por: O’Sullivan, Jeremy A., et al.
Publicado: (2017)

Editorial: Recent advances in keratinocyte carcinomas: From molecular mechanisms to clinical perspectives
por: Caruntu, Constantin, et al.
Publicado: (2022)

Editorial: Functional Imaging of Inflammation and Infection
por: Lawal, Ismaheel O., et al.
Publicado: (2022)

Editorial: Uveal melanoma: from lab bench to clinic – new therapeutic advances
por: D'Amico, Agata Grazia, et al.
Publicado: (2023)

Editorial: Advances in stem cell therapy: new applications and innovative therapeutic approaches
por: Marcuzzi, Annalisa, et al.
Publicado: (2023)

Editorial: Autoimmune blistering diseases: advances in the understanding of pathogenesis and new therapeutic horizons
por: Gasparini, Giulia, et al.
Publicado: (2023)

Editorial: Inflammation and Biomarkers in Osteoarthritis
por: Mobasheri, Ali, et al.
Publicado: (2021)

Eosinophils, beyond IL-5
por: Esnault, Stephane, et al.
Publicado: (2021)

Editorial: Long-term perspectives in advanced heart failure therapies
por: Schoenrath, Felix, et al.
Publicado: (2023)

Insights from Social Media on the Patient Experience of Living With Rare Eosinophil-Driven Diseases
por: Strobel, Mary Jo, et al.
Publicado: (2022)

Integrin Activation States and Eosinophil Recruitment in Asthma
por: Johansson, Mats W., et al.
Publicado: (2013)

Proteomics of Eosinophil Activation
por: Mosher, Deane F., et al.
Publicado: (2017)

Editorial: Advances in Molecular Cytopathology
por: Vigliar, Elena, et al.
Publicado: (2022)

Editorial: Molecular Bridges Between Hematology and Inflammation
por: Kasirer-Friede, Ana
Publicado: (2019)

Editorial: Updates in ocular therapeutics and surgery
por: Panos, Georgios D., et al.
Publicado: (2023)

Eosinophilic Ascites: A Rare Case Report With Diagnostic and Therapeutic Challenges
por: Devi, Sujata, et al.
Publicado: (2020)

Eosinophilic Ascites: An Infrequent Presentation of Eosinophilic Gastroenteritis
por: Sequeira, Mafalda, et al.
Publicado: (2022)

Mepolizumab therapy improves the most bothersome symptoms in patients with hypereosinophilic syndrome
por: Roufosse, Florence, et al.
Publicado: (2023)

Eosinophilic Gastrointestinal Disorders Pathology
por: Collins, Margaret H., et al.
Publicado: (2018)

Eosinophilic Esophagitis: Review and Update
por: Gomez Torrijos, Elisa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jkjsh12lkupv1f7ovblji287ju